|
Isolated giant cell
myocarditis in the atrium: an incidental finding?Pacing
Clin Electrophysiol. 2006 Oct;29(10):1179-80.
Giant cell myocarditis
(GCM) is an uncommon disorder that affects ventricular myocardium causing
severe left ventricular dysfunction and ventricular arrhythmias. We report a
case of GCM that only affected the atrium sparing the ventricle.
Giant cell myocarditis--a
rare, but dangerous disease.Tidsskr
Nor Laegeforen. 2005 Aug 25;125(16):2198-201.
BACKGROUND:
Myocarditis is defined as an inflammatory or infectious disease of the
myocardium causing damage through production of a toxin or by
immunologically mediated destruction. A rare type is idiopathic giant cell
myocarditis. MATERIAL AND METHODS: We present data from Rikshospitalet
University Hospital in Norway, with two case reports and a discussion of the
diagnostics and treatments currently available. The investigation is
retrospective and includes 11 patients, two women and nine men with
histologically verified idiopathic giant cell myocarditis. RESULTS: Median
age was 46; four patients had autoimmune co-morbidity. The major onset
symptom was rapid progressive heart failure; 64% had concomitant ventricular
arrhythmias. Five patients received immunosuppressives in addition to
conventional treatment for heart failure. Eight underwent cardiac
transplantation and two patients had recurrence of idiopathic giant cell
myocarditis in the graft. Mean interval from time of diagnosis to death or
cardiac transplantation was six months. INTERPRETATION: Idiopathic giant
cell myocarditis is a rare inflammatory disease of the myocardium that often
affects previously healthy young adults. Co-morbidity with autoimmune
disorders has been reported. Idiopathic giant cell myocarditis is
characterised by a history of rapid progression of severe heart failure
associated with refractory ventricular arrhythmias. The diagnosis is made by
endomyocardial biopsy. Treatment includes immunosuppressives, and the
indication for cardiac transplantation should be evaluated early, as one
should bear in mind an increased risk of recurrence in the graft. |